- Home
- NVCT vs SRTS Comparison
NVCT vs SRTS Comparison
Compare NVCT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- SRTS
- Stock Information
- Founded
- NVCT 2020
- SRTS 2010
- Country
- NVCT United States
- SRTS United States
- Employees
- NVCT N/A
- SRTS N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- SRTS Medical/Dental Instruments
- Sector
- NVCT Health Care
- SRTS Health Care
- Exchange
- NVCT Nasdaq
- SRTS Nasdaq
- Market Cap
- NVCT 107.8M
- SRTS 110.3M
- IPO Year
- NVCT 2022
- SRTS 2016
- Fundamental
- Price
- NVCT $5.71
- SRTS $6.84
- Analyst Decision
- NVCT Strong Buy
- SRTS Strong Buy
- Analyst Count
- NVCT 1
- SRTS 2
- Target Price
- NVCT $21.00
- SRTS $12.50
- AVG Volume (30 Days)
- NVCT 104.2K
- SRTS 236.2K
- Earning Date
- NVCT 03-04-2025
- SRTS 02-06-2025
- Dividend Yield
- NVCT N/A
- SRTS N/A
- EPS Growth
- NVCT N/A
- SRTS N/A
- EPS
- NVCT N/A
- SRTS 0.57
- Revenue
- NVCT N/A
- SRTS $41,308,000.00
- Revenue This Year
- NVCT N/A
- SRTS $65.04
- Revenue Next Year
- NVCT N/A
- SRTS $24.87
- P/E Ratio
- NVCT N/A
- SRTS $12.02
- Revenue Growth
- NVCT N/A
- SRTS 65.62
- 52 Week Low
- NVCT $4.44
- SRTS $2.91
- 52 Week High
- NVCT $12.10
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- NVCT 53.18
- SRTS 43.96
- Support Level
- NVCT $5.34
- SRTS $6.53
- Resistance Level
- NVCT $5.89
- SRTS $6.93
- Average True Range (ATR)
- NVCT 0.50
- SRTS 0.38
- MACD
- NVCT 0.02
- SRTS -0.00
- Stochastic Oscillator
- NVCT 39.53
- SRTS 37.10
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.